A BILL TO BE ENTITLED
AN ACT to add Mephedrone, METHYENEDIOXYPROVALERONE AND CERTAIN DERIVITIVES OF 2‑AMINO‑1‑PHENYL‑1‑PROPANONE to the list of controlled substances.
The General Assembly of North Carolina enacts:
SECTION 1.  G.S. 90‑89(5) reads as rewritten:
"§ 90‑89. Schedule I controlled substances.
This schedule includes the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated. In determining that a substance comes within this schedule, the Commission shall find: a high potential for abuse, no currently accepted medical use in the United States, or a lack of accepted safety for use in treatment under medical supervision. The following controlled substances are included in this schedule:
…
(5)	Stimulants. – Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
a.	Aminorex. Some trade or other names: aminoxaphen; 2‑amino‑5‑phenyl‑2‑oxazoline; or 4,5‑dihydro‑5‑phenly‑2‑oxazolamine.
b.	Cathinone. Some trade or other names: 2‑amino‑1‑phenyl‑1‑propanone, alpha‑aminopropiophenone, 2‑aminopropiophenone, and norephedrone.
c.	Fenethylline.
d.	Methcathinone. Some trade or other names: 2‑(methylamino)propiophenone, alpha‑(methylamino)propiophenone, 2‑(methylamino)‑1‑phenylpropan‑1‑one, alpha‑N‑methylaminopropiophenone, monomethylproprion, ephedrone, N‑methylcathinone, methylcathinone, AL‑464, AL‑422, AL‑463, and UR1432.
e.	(+/‑)cis‑4‑methylaminorex [(+/‑)cis‑4,5‑dihydro‑4‑methyl‑5‑phenyl‑2‑oxazolamine]  (also known as 2‑amino‑4‑methyl‑5‑phenyl‑2‑oxazoline).
f.	N,N‑dimethylamphetamine. Some other names: N,N,alpha‑trimethylbenzeneetha neamine; N,N,alpha‑trimethylphenethyla mine.
g.	N‑ethylamphetamine. 
h.	4‑methylmethcathinone (also known as mephedrone).
i.	Methyenedioxypyrovalerone (also known as MDPV).
j.	A compound, other than buproprion, that is structurally derived from 2‑amino‑1‑phenyl‑1‑propanone by modification in any of the following ways: (i) by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents; (ii) by substitution at the 3‑position with an alkyl substituent; (iii) by substitution at the nitrogen atom with alkyl or diakyl groups, or by inclusion of the nitrogen atom in a cyclic structure."
SECTION 2.  This act becomes effective April 1, 2011, and applies to offenses committed on or after that date.